Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Ghrelin in Frail Elderly Subcutaneous Repeated Dose Study
Authors not listed
University of Pennsylvania · 2013
Abstract
Frailty is a geriatric syndrome leading to physical deterioration including muscle wasting (sarcopenia) and unintentional weight loss. There are currently no approved therapies for frailty. Ghrelin is a hormone produced by the stomach that stimulates appetite centers in the brain. The investigators already know that a single dose of Ghrelin improves food intake immediately after the dose in frail older people. In this study, the investigators are trying to find out if repeated daily doses of ghrelin will help frail older people improve food intake for multiple days in a row.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Anonymous. (2013). Ghrelin in Frail Elderly Subcutaneous Repeated Dose Study. <em>University of Pennsylvania</em>. https://clinicaltrials.gov/study/NCT01833078
Vancouver
Anonymous. Ghrelin in Frail Elderly Subcutaneous Repeated Dose Study. University of Pennsylvania. 2013.
BibTeX
@misc{anon2013Ghreli,
title = {Ghrelin in Frail Elderly Subcutaneous Repeated Dose Study},
author = {Anonymous},
journal = {University of Pennsylvania},
year = {2013},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Pennsylvania 2013
Open access · US-GOV
Ghrelin Plus Strength Training in Frail Elderly Study
University of Pennsylvania 2012
Open access · US-GOV
Ghrelin In Frail Elderly Subcutaneous Dose Finding Study
Gerencia de Atención Primaria, Madrid 2014
Open access · US-GOV
Cardiovascular Risk in People Older Than 55 Years and Cognitive Performance at 5 Years: an Estimation Model Based on Spanish Population. NEDICES-2-RISK Study.
University of Pennsylvania 2007
Open access · US-GOV
A Pilot Study of Ghrelin in Healthy and Frail Older Women
Cell 2020
Open access · OA
Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease
University of Virginia 2003
Open access · US-GOV